These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28807749)

  • 21. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
    Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
    Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
    Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
    Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brachytherapy in the treatment of Stage IV carcinoma of the base of tongue.
    Cano ER; Johnson JT; Carrau R; Agarwala S; Flickinger J; Quader M
    Brachytherapy; 2004; 3(1):41-8. PubMed ID: 15110313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose rate brachytherapy for early stage oral tongue cancer.
    Leung TW; Wong VY; Kwan KH; Ng TY; Wong CM; Tung SY; Leung LC; O SK
    Head Neck; 2002 Mar; 24(3):274-81. PubMed ID: 11891960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of treatment time on outcome of radiotherapy for oral tongue carcinoma.
    Hosokawa Y; Shirato H; Nishioka T; Tsuchiya K; Chang TC; Kagei K; Ohomori K; Obinata K; Kaneko M; Miyasaka K; Nakamura M
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):71-8. PubMed ID: 12909217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
    Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
    Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
    Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue.
    Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Ishii J; Komori T
    Int J Oral Maxillofac Surg; 2005 Oct; 34(7):739-44. PubMed ID: 15921890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue.
    Ihara N; Shibuya H; Yoshimura R; Oota S; Miura M; Watanabe H
    Acta Oncol; 2005; 44(7):709-16. PubMed ID: 16227161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
    Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative hyperfractionated high-dose rate brachytherapy for the treatment of soft tissue sarcomas: multicentric experience.
    Petera J; Soumarová R; Růzicková J; Neumanová R; Dusek L; Sirák I; Macingová Z; Paluska P; Kasaová L; Hodek M; Vosmik M
    Ann Surg Oncol; 2010 Jan; 17(1):206-10. PubMed ID: 19711130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer.
    Matsumoto K; Sasaki T; Shioyama Y; Nakamura K; Atsumi K; Nonoshita T; Ooga S; Yoshitake T; Uehara S; Hirata H; Honda H
    Jpn J Clin Oncol; 2013 Oct; 43(10):1012-7. PubMed ID: 23906605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis.
    Boukhelif W; Ferri-Molina M; Mazeron R; Maroun P; Duhamel-Oberlander AS; Dumas I; Martinetti F; Guemnie-Tafo A; Chargari C; Haie-Meder C
    Brachytherapy; 2015; 14(4):549-53. PubMed ID: 25935731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of patients with localized and locally advanced prostate cancer undergoing high-dose-rate brachytherapy with external-beam radiotherapy at our institute.
    Makino T; Mizokami A; Namiki M
    Anticancer Res; 2015 Mar; 35(3):1723-8. PubMed ID: 25750334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
    Unetsubo T; Matsuzaki H; Takemoto M; Katsui K; Hara M; Katayama N; Waki T; Kanazawa S; Asaumi J
    Radiat Oncol; 2015 Apr; 10():81. PubMed ID: 25888772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
    Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.